Actively Recruiting
Proximal Priority Versus Distal Priority Robotic Priming Effects in Patients With Chronic Stroke
Led by National Taiwan University Hospital · Updated on 2026-02-25
72
Participants Needed
4
Research Sites
312 weeks
Total Duration
On this page
Sponsors
N
National Taiwan University Hospital
Lead Sponsor
N
National Health Research Institutes, Taiwan
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a single-blind randomized comparative efficacy study involving 54-72 participants with chronic stroke. Participants will be randomized into proximal priority robotic group or distal priority robotic group and receive 18 intervention sessions (90 min/d, 3 d/wk for 6 weeks). The Fugl-Meyer Assessment Upper Extremity subscale, Medical Research Council Scale, Revised Nottingham Sensory Assessment, and Wolf Motor Function Test will be administered at baseline, after treatment, and at the 3-month follow-up. Two-way repeated-measures analysis of variance and the Chi-Square Automatic Interaction Detector Method will be used to examine the comparative efficacy and predictors of outcome, respectively, after intervention.
CONDITIONS
Official Title
Proximal Priority Versus Distal Priority Robotic Priming Effects in Patients With Chronic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 20 and 75 years old
- More than 3 months after first unilateral ischemic or hemorrhagic stroke
- Moderate to severe upper extremity motor impairment (Fugl-Meyer Assessment score between 18 and 56)
- No severe spasticity (modified Ashworth Scale score less than 3) in affected shoulder, elbow, wrist, or fingers
- Able to follow instructions (Mini-Mental State Examination score greater than 24)
- No upper extremity fractures in the past 3 months
- Not currently participating in other medication or rehabilitation studies
You will not qualify if you...
- Presence of other neurological, neuromuscular, or orthopedic diseases such as epilepsy
- Severe health or physical conditions that could prevent participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
National Taiwan University Hospital
Taipei, Taipei, Taiwan, 100
Actively Recruiting
2
Taipei Tzu Chi Hospital
New Taipei City, Taiwan
Actively Recruiting
3
Fongyuan Hospital
Taichung, Taiwan
Actively Recruiting
4
Taipei Municipal Wan Fang Hospital
Taipei, Taiwan, 116
Actively Recruiting
Research Team
K
Kehchung Lin, ScD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here